Technology
Health
Biotechnology

Matinas BioPharma

$0.9882
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0082 (0.84%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell MTNB and other stocks, options, ETFs, and crypto commission-free!

About

Matinas BioPharma Holdings, Inc., also called Matinas BioPharma, is a clinical-stage biopharmaceutical company, which focuses on enabling the delivery of life-changing medicines using its LNC platform technology. The company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. Read More Its anti-fungal product candidate, MAT2203, delivers broad-spectrum fungicidal agent, amphotericin B; and is being developed to prevent invasive fungal infections in patients with acute lymphoblastic leukemia. The company was founded in May 2013 and is headquartered in Bedminster, NJ.

Employees
15
Headquarters
Bedminster, New Jersey
Founded
2013
Market Cap
141.30M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.35M
High Today
$0.9899
Low Today
$0.96
Open Price
$0.9834
Volume
405.24K
52 Week High
$1.50
52 Week Low
$0.3237

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
2017 IPO
US

News

Seeking AlphaMay 14

Matinas BioPharma Holdings, Inc. CEO Jerry Jabbour on Q1, 2019 Results - Earnings Call Transcript

Matinas BioPharma Holdings, Inc. Q1 2019 Earnings Conference Call May 14, 2019 8:30 AM ET Company Participants Jenene Thomas - IR Jerry Jabbour - Chief Executive Officer Conference Call Participants Robert Hazlett - BTIG Operator Greetings and welcome to the Matinas BioPharma Quarterly Update Conference Call and Webcast. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is...

238
NasdaqMay 8

Matinas BioPharma to Host Conference Call and Webcast to Discuss First Quarter 2019 Operational and Financial Results on May 14, 2019

BEDMINSTER, N.J., May 08, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company, today announced that the Company will host a conference call and live audio webcast on Tuesday, May 14, 2019 at 8:30 a.m. ET to discuss operational and financial results for the quarter ended March 31, 2019 as well as provide a corporate update. To participate in the call, please dial (877) 407-5976 (domestic) or (412) 902-0031 (international). The live web...

206
Yahoo FinanceMay 6

Opening Bell, May 6, 2019

214

Earnings

-$0.05
-$0.04
-$0.04
-$0.03
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.03 per share
Actual
-$0.04 per share

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.